Seminars in Liver Disease

Papers
(The H4-Index of Seminars in Liver Disease is 15. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Hepatic Extracellular Matrix and Its Role in the Regulation of Liver Phenotype74
Liver Immunology, Immunotherapy, and Liver Cancers: Time for a Rethink?37
Critical Care Management of Acute-on-Chronic Liver Failure: Certainties and Unknowns32
Tight Junction Proteins as Therapeutic Targets to Treat Liver Fibrosis and Hepatocellular Carcinoma32
A Precision Medicine Guided Approach to the Utilization of Biomarkers in MASLD30
Tailored Model of Care for Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease25
Genetic and Epigenetic Basis of Drug-Induced Liver Injury24
HBV Biomarkers and Their Role in Guiding Treatment Decisions23
Patient-Reported Outcomes in Metabolic Dysfunction-Associated Steatotic Liver Disease21
Emerging Targets for the Treatment of Primary Sclerosing Cholangitis20
Genetic Contributions to Biliary Atresia: A Developmental Cholangiopathy18
Mechanisms of Pharmacoresistance in Hepatocellular Carcinoma: New Drugs but Old Problems16
Growth Hormone Signaling in Liver Diseases: Therapeutic Potentials and Controversies16
Mice Engrafted with Human Liver Cells16
Physiomimetic In Vitro Human Models for Viral Infection in the Liver15
0.18037295341492